髓过氧化物酶
神经炎症
小胶质细胞
氧化应激
药理学
下调和上调
炎症
海马结构
医学
鼻腔给药
淀粉样蛋白(真菌学)
免疫学
免疫系统
神经保护
神经科学
先天免疫系统
转录组
化学
认知功能衰退
活性氧
癌症研究
β淀粉样蛋白
作者
Jing Wang,Peilin Cong,Enduo Feng,Matthias W. G. Zeller,Boyu Zhang,Yifan Lv,Negin Jalali Motlagh,Jenny Linnoila,Han Wang,Cuihua Wang,Zhiming Xu,Ke Gao,Qian Chen,Yu Luo,He Wang,Dalong Ni,Lize Xiong,John W. Chen
标识
DOI:10.1073/pnas.2603280123
摘要
Chronic neuroinflammation and oxidative stress are important contributors to Alzheimer's disease (AD). Myeloperoxidase (MPO), a key driver of oxidative inflammation released mainly by activated microglia in the neurodegenerative brain, is a potential therapeutic target to inhibit the neuroinflammatory cascade and oxidative damage in AD, but the underlying mechanisms remain unexplored, and achieving targeted brain delivery of an MPO inhibitor and minimizing systemic effects remain significant challenges. We addressed these limitations by first establishing that genetic deletion of MPO in the 5XFAD mouse model improved memory performance and reduced amyloid deposition, validating MPO as a therapeutic target. We then developed a liposome-encapsulated reactive oxygen species (ROS)-activatable MPO inhibitor (LERAMI). LERAMI uniquely combines targeted delivery with on-demand drug release, utilizing a ROS-sensitive linker to selectively release MPO inhibitors in ROS-rich regions within the AD microenvironment, minimizing off-target effects and systemic toxicity. In the 5XFAD mouse model. By reducing MPO expression and activity, LERAMI significantly improved cognitive performance, accompanied by decreased microglial activation, attenuated oxidative DNA damage, improved synaptic and neuronal density, and reduced amyloid burden. RNA sequencing revealed a robust hippocampal transcriptomic reprogramming, with upregulation of pathways critical for synaptic plasticity, calcium signaling, axon guidance, and neuroprotection, along with downregulation of inflammatory and immune response pathways. These findings demonstrate that targeted ROS-activatable MPO inhibition with LERAMI represents a promising therapeutic strategy for AD and potentially other neuroinflammatory diseases, offering a unique approach to mitigate neuroinflammation, preserve synaptic integrity, and restore cognitive function.
科研通智能强力驱动
Strongly Powered by AbleSci AI